½ÃÀ庸°í¼­
»óǰÄÚµå
1789429

¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå : ¿ä½Ç±Ý À¯Çüº°, Á¦Ç° À¯Çüº°, »ç¿ë À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚ º´¿øº°, À¯Åë ä³Îº°, Áö¿ªº°

Male Urinary Incontinence Market, By Type of Incontinence, By Product Type Absorbent Products, By End User Hospitals, By Distribution Channel, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³²¼º ¿ä½Ç±Ý ½ÃÀå 2025³â ½ÃÀå ±Ô¸ð´Â 68¾ï 2,000¸¸ ´Þ·¯, 2032³â¿¡´Â 101¾ï 9,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 5.9%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 68¾ï 2,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â 5.90% 2032³â ±Ý¾× ¿¹Ãø 101¾ï 9,000¸¸ ´Þ·¯

¼¼°è ³²¼º ¿ä½Ç±Ý ½ÃÀåÀº Àü ¼¼°è ¼ö¹é¸¸ ¸íÀÇ ³²¼º¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ½¿¡µµ ºÒ±¸Çϰí Àß º¸°íµÇÁö ¾Ê´Â ÁúȯÀ» ´Ù·ç°í ÀÖ´Â ±¤¹üÀ§ÇÑ ÇコÄÉ¾î »ê¾÷¿¡¼­ Áß¿äÇÑ ºÎ¹®ÀÔ´Ï´Ù. ³²¼º ¿ä½Ç±ÝÀº ¹æ±¤À» Á¶ÀýÇÒ ¼ö ¾ø´Â °ÍÀÌ Æ¯Â¡À̸ç, ½ºÆ®·¹½º¼º ¿ä½Ç±Ý, Àý¹Ú¼º ¿ä½Ç±Ý, Àý¹Ú¼º ¿ä½Ç±Ý, Àý¹Ú¼º ¿ä½Ç±Ý, È¥ÇÕ¼º ¿ä½Ç±Ý µî ´Ù¾çÇÑ À¯ÇüÀÌ ÀÖÀ¸¸ç, °¢ À¯Çü¸¶´Ù °íÀ¯ÇÑ ÀÓ»óÀû ¹®Á¦¿Í Ä¡·á ¿ä°ÇÀÌ ÀÖ½À´Ï´Ù. ÀÌ ÁúȯÀº ÁÖ·Î °í·ÉÀÇ ³²¼ºÀÌ ÁÖ·Î ¹ßº´Çϸç, ¿¬·ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó À¯º´·üÀÌ ÇöÀúÇÏ°Ô Áõ°¡ÇÏÁö¸¸ Àü¸³¼± ¼ö¼ú, ½Å°æÀå¾Ö, ¿Ü»ó µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ÀþÀº »ç¶÷¿¡°Ôµµ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀå¿¡´Â ¿ä½Ç±ÝÀÇ ±Ùº»ÀûÀÎ ¿øÀÎÀ» °ü¸®Çϰųª Ä¡·áÇϱâ À§ÇØ ¼³°èµÈ Èí¼ö¼º Á¦Ç°, ¿ÜºÎ Ä«Å×ÅÍ, À̽ÄÇü ±â±â, ¾à¹° ÁßÀç, ¿Ü°úÀû ½Ã¼ú µîÀÇ Á¾ÇÕÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀÌ Æ÷ÇԵ˴ϴÙ. ³²¼º ¿ä½Ç±ÝÀº »îÀÇ Áú, »çȸÀû ±â´É, ½É¸®Àû ¾È³ç¿¡ ½É°¢ÇÑ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ½¿¡µµ ºÒ±¸ÇÏ°í ¿©ÀüÈ÷ ³«ÀÎÀÌ ÂïÇô ÀÖ¾î, ȯÀÚµéÀÇ Áø´ÜÀÌ ´Ê¾îÁö°í Ä¡·á¸¦ ¹ÞÀ¸·Á´Â ÇൿÀÌ ´Ê¾îÁö°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è ³²¼º ¿ä½Ç±Ý ½ÃÀåÀº ÁÖ·Î ÀÌ Ä¡·á ºÐ¾ß ½ÃÀå È®´ë¿Í ±â¼ú Çõ½ÅÀ» ÃÑüÀûÀ¸·Î ÃËÁøÇÏ´Â ¸î °¡Áö »óÈ£ ¿¬°üµÈ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­´Â °¡Àå Áß¿äÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ̸ç, ¿ä½Ç±Ý À¯º´·üÀº ¿¬·É¿¡ µû¶ó, ƯÈ÷ 65¼¼ ÀÌ»ó ³²¼ºÀÇ ¿ä½Ç±Ý À¯º´·üÀÌ Å©°Ô Áõ°¡ÇÏ¿© °ü¸® ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÑ È¯ÀÚ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ±â°ü°ú ¿ËÈ£ ´ÜüÀÇ ÀÎ½Ä °³¼± Ä·ÆäÀΰú ±³À° ÀÌ´Ï¼ÅÆ¼ºê°¡ Áõ°¡ÇÔ¿¡ µû¶ó ³²¼º ¿ä½Ç±Ý¿¡ ´ëÇÑ Æí°ßÀÌ Á¡Â÷ »ç¶óÁö°í ÀÖÀ¸¸ç, ´õ ¸¹Àº ³²¼ºµéÀÌ Àü¹®ÀÇÀÇ µµ¿òÀ» ¹Þ°í ÀûÀýÇÑ Ä¡·á¹ýÀ» ¼±ÅÃÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÷´Ü Àΰø¿äµµ°ý¾à±Ù, ³²¼º¿ë ½½¸µ, ÃÖ¼Òħ½À¼ö¼ú ±â¼ú °³¹ß µî ÀÇ·á±â±âÀÇ ±â¼úÀû ¹ßÀüÀº Ä¡·áÀÇ °¡´É¼ºÀ» ³ÐÈ÷°í ȯÀÚµéÀÇ Ä¡·á °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¼ö¼úÀû Ä¡·á°¡ ÇÊ¿äÇÑ Àü¸³¼±ºñ´ëÁõÀ̳ª Àü¸³¼±¾Ï°ú °°Àº Àü¸³¼± °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ³²¼º ¿ä½Ç±Ý ¹ß»ý·ü¿¡ Á÷Á¢ÀûÀ¸·Î ±â¿©Çϰí ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ ¿¹¹æ ¹× Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ Áúȯ°ú °ü·ÃµÈ »çȸÀû ³«Àΰú ¼öÄ¡½É µî ½É°¢ÇÑ ¾ïÁ¦¿äÀο¡ Á÷¸éÇØ ÀÖ¾î ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖÀ¸¸ç, ÀÌ´Â °ú¼Òº¸°í¿Í Áø´Ü Áö¿¬À¸·Î À̾îÁ® ½ÃÀå ħÅõ¸¦ Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ÷´Ü ¼ö¼úÀ̳ª À̽ÄÇü ÀÇ·á±â±â¿¡ ´ëÇÑ °í°¡ÀÇ Ä¡·áºñ´Â ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó³ª º¸Çè Àû¿ëÀÌ Á¦ÇÑÀûÀÎ °³¹ßµµ»ó±¹¿¡¼­´Â Á¢±Ù¼ºÀ» °¡·Î¸·´Â Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á±â±â ½ÂÀΰú ¾à»ç¹ýÀû °³ÀÔÀ» µÑ·¯½Ñ ±ÔÁ¦ÀÇ º¹À⼺À¸·Î ÀÎÇØ Á¦Ç° Ãâ½Ã°¡ Áö¿¬µÇ°í, Á¦Á¶¾÷üÀÇ °³¹ß ºñ¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ÀÇ·áºñ ÁöÃâ Áõ°¡°¡ ½ÃÀå È®´ëÀÇ »õ·Î¿î ±æÀ» ¿­¾îÁÖ´Â ½ÅÈï ½ÃÀå¿¡´Â Å« ºñÁî´Ï½º ±âȸ°¡ Á¸ÀçÇϸç, Àç»ýÀÇ·á ¹× »ýü°øÇÐ ¼Ö·ç¼Ç°ú °°Àº »õ·Î¿î Ä¡·á Á¢±Ù¹ý¿¡ ´ëÇÑ ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸´Â Ä¡·á ÆÐ·¯´ÙÀÓÀ» ¹Ù²Ù°í ¹Ì°³Ã´ ½ÃÀå ÀáÀç·ÂÀ» È®º¸ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù. °ÍÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« ¹× ±âŸ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ³²¼º ¿ä½Ç±Ý ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ³²¼º ¿ä½Ç±Ý ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ °ü°èÀÚ´Â ¼¼°è ³²¼º ¿ä½Ç±Ý ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • ¿µÇ⠺м®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
  • »ê¾÷ µ¿Çâ

Á¦4Àå ¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå, ¿ä½Ç±Ý À¯Çüº°, 2020-2032³â

  • ¼­·Ð
  • º¹¾Ð¼º ¿ä½Ç±Ý
  • Àý¹Ú¼º ¿ä½Ç±Ý
  • ÀÏ·ù¼º ¿ä½Ç±Ý
  • ±â´É¼º ¿ä½Ç±Ý
  • È¥ÇÕ¼º ¿ä½Ç±Ý(º¹¾Ð¼º£«ÀÓ¹Ú¼º)

Á¦5Àå ¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

  • ¼­·Ð
  • Èí¼ö¼º Á¦Ç°
  • ÆÐµå ¹× °¡À̵å
  • ¿ÜºÎ Ä«Å×ÅÍ(¿äµµ ½Ã½º)
  • ¶óÅØ½º ½Ã½º
  • ³»ºÎ Ä«Å×ÅÍ
  • À¯Ä¡Çü(Æú¸®) Ä«Å×ÅÍ
  • °£Çæ Ä«Å×ÅÍ
  • ±âŸ µð¹ÙÀ̽º ¹× ½Ã½ºÅÛ
  • ³²¼º¿ë ½½¸µ

Á¦6Àå ¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå, ¿¬·ÉÃþº°, 2020-2032³â

  • ¼­·Ð
  • 18-39¼¼
  • 40-59¼¼
  • 60-74¼¼
  • 75¼¼ ÀÌ»ó

Á¦7Àå ¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå, »ç¿ë À¯Çüº°, 2020-2032³â

  • ¼­·Ð
  • ÀçÀÌ¿ë °¡´É
  • ÀÏȸ¿ë

Á¦8Àå ¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

  • ¼­·Ð
  • º´¿ø
  • ºñ´¢±â°ú Ŭ¸®´Ð
  • ÀçÅà ÇコÄɾî ȯ°æ
  • Àå±â ÄÉ¾î ¼¾ÅÍ/¿ä¾ç½Ã¼³
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â

  • ¼­·Ð
  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦10Àå ¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ¼­·Ð
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ASEAN ±¹°¡
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
    • GCC ±¹°¡
    • À̽º¶ó¿¤
    • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • ºÏ¾ÆÇÁ¸®Ä«
    • Áß¾Ó¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • Coloplast A/S
  • ConvaTec Group PLC
  • Hollister Incorporated
  • Kimberly-Clark Corporation
  • Medtronic PLC
  • Boston Scientific Corporation
  • Braun Melsungen AG
  • Teleflex Incorporated
  • Wellspect HealthCare
  • Procter and Gamble Co.
  • AbbVie Inc.
  • Pfizer Inc.
  • Laboratoires URGO
  • Ontex Healthcare
  • R. Bard(BD)

Á¦12Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • ±âȸ
  • COP(Coherent Opportunity Map)

Á¦13Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 25.08.19

Male Urinary Incontinence Market is estimated to be valued at USD 6.82 Bn in 2025 and is expected to reach USD 10.19 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.82 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.90% 2032 Value Projection: USD 10.19 Bn

The global male urinary incontinence market represents a critical segment within the broader healthcare industry, addressing a prevalent yet often underreported condition affecting millions of men worldwide. Male urinary incontinence, characterized by the involuntary loss of bladder control, encompasses various types including stress incontinence, urge incontinence, overflow incontinence, and mixed incontinence, each presenting unique clinical challenges and treatment requirements. This condition predominantly affects older men, with prevalence rates increasing significantly with age, though it can also impact younger individuals due to factors such as prostate surgery, neurological disorders, or traumatic injuries.

The market encompasses a comprehensive range of therapeutic solutions including absorbent products, external catheters, implantable devices, pharmaceutical interventions, and surgical procedures designed to manage or treat the underlying causes of incontinence. Despite the significant impact on quality of life, social functioning, and psychological well-being, male urinary incontinence remains stigmatized, leading to underdiagnosis and delayed treatment seeking behavior among affected individuals, which consequently influences market dynamics and growth patterns across different geographical regions.

Market Dynamics

The global male urinary incontinence market is primarily driven by several interconnected factors that collectively propel market expansion and innovation within this therapeutic area. The aging global population serves as the most significant market driver, as the prevalence of urinary incontinence increases substantially with age, particularly among men over 65 years, creating a growing patient pool requiring management solutions. Rising awareness campaigns and educational initiatives by healthcare organizations and advocacy groups are gradually reducing the stigma associated with male incontinence, encouraging more men to seek professional medical help and appropriate treatment options. Technological advancements in medical devices, including the development of sophisticated artificial urinary sphincters, male slings, and minimally invasive surgical techniques, are expanding treatment possibilities and improving patient outcomes.

Additionally, the increasing prevalence of prostate-related disorders, including benign prostatic hyperplasia and prostate cancer requiring surgical intervention, directly contributes to the incidence of male urinary incontinence, thereby driving demand for both preventive and therapeutic solutions. However, market growth faces significant restraints including persistent social stigma and embarrassment associated with the condition, leading to underreporting and delayed diagnosis, which limits market penetration. High treatment costs, particularly for advanced surgical procedures and implantable devices, pose substantial barriers to access, especially in developing regions with limited healthcare infrastructure and insurance coverage. Regulatory complexities surrounding medical device approvals and pharmaceutical interventions can delay product launches and increase development costs for manufacturers. Nevertheless, substantial opportunities exist within emerging markets where improving healthcare infrastructure and increasing healthcare expenditure create new avenues for market expansion, while ongoing research into novel therapeutic approaches, including regenerative medicine and bioengineered solutions, promises to revolutionize treatment paradigms and capture untapped market potential.

Key Features of the Study

  • This report provides an in-depth analysis of the global male urinary incontinence market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global male urinary incontinence market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Kimberly-Clark Corporation, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Wellspect HealthCare, Procter and Gamble Co., AbbVie Inc., Pfizer Inc., Laboratoires URGO, Ontex Healthcare, and C. R. Bard (BD).
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global male urinary incontinence market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global male urinary incontinence market.

Market Segmentation

  • Type of Incontinence Insights (Revenue, USD Bn, 2020 - 2032)
    • Stress Urinary Incontinence
    • Urge Urinary Incontinence
    • Overflow Urinary Incontinence
    • Functional Urinary Incontinence
    • Mixed Incontinence (Stress + Urge)
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Absorbent Products
    • Pads and Guards
    • Adult Diapers
    • Protective Underwear
    • Bed Protectors and Mattress Covers
    • External Catheters (Urinary Sheaths)
    • Latex Sheaths
    • Silicone Sheaths
    • Hydrocolloid Sheaths
    • Internal Catheters
    • Indwelling (Foley) Catheters
    • Intermittent Catheters
    • Other Devices and Systems
    • Male Slings
    • Artificial Urinary Sphincters
    • Electrical Stimulation Devices/Penile Clamps
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • 18-39 Years
    • 40-59 Year
    • 60-74 Years
    • 75 Years and Above
  • Usage Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Reusable
    • Disposable
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Urology Clinics
    • Home Healthcare Settings
    • Long-Term Care Centers / Nursing Homes
    • Ambulatory Surgical Centers
    • Others
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Offline
    • Online
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Coloplast A/S
    • ConvaTec Group PLC
    • Hollister Incorporated
    • Kimberly-Clark Corporation
    • Medtronic PLC
    • Boston Scientific Corporation
    • Braun Melsungen AG
    • Teleflex Incorporated
    • Wellspect HealthCare
    • Procter and Gamble Co.
    • AbbVie Inc.
    • Pfizer Inc.
    • Laboratoires URGO
    • Ontex Healthcare
    • R. Bard (BD)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Male Urinary Incontinence Market, By Type of Incontinence
    • Global Male Urinary Incontinence Market, By Product Type
    • Global Male Urinary Incontinence Market, By Age Group
    • Global Male Urinary Incontinence Market, By Usage Type
    • Global Male Urinary Incontinence Market, By End User
    • Global Male Urinary Incontinence Market, By Distribution Channel

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Male Urinary Incontinence Market, By Type of Incontinence, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stress Urinary Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urge Urinary Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Overflow Urinary Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Functional Urinary Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mixed Incontinence (Stress + Urge)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Male Urinary Incontinence Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Absorbent Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pads and Guards
    • Adult Diapers
    • Protective Underwear
    • Bed Protectors and Mattress Covers
  • External Catheters (Urinary Sheaths)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Latex Sheaths
    • Silicone Sheaths
    • Hydrocolloid Sheaths
  • Internal Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Indwelling (Foley) Catheters
  • Intermittent Catheters
  • Other Devices and Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Male Slings
    • Artificial Urinary Sphincters
    • Electrical Stimulation Devices/Penile Clamps

6. Global Male Urinary Incontinence Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 18-39 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 40-59 Year
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 60-74 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 75 Years and Above
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Male Urinary Incontinence Market, By Usage Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Reusable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Disposable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Male Urinary Incontinence Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urology Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Healthcare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Long-Term Care Centers / Nursing Homes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Male Urinary Incontinence Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Offline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Male Urinary Incontinence Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Sub-region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Coloplast A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ConvaTec Group PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hollister Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Kimberly-Clark Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teleflex Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Wellspect HealthCare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Procter and Gamble Co.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Laboratoires URGO
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ontex Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • R. Bard (BD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦